Synthesis and Antimicrobial Activity of Silver-Doped Hydroxyapatite Nanoparticles

<table>Graphic representation of the minimal inhibitory concentrations (MIC) and biofilm active concentration <svg height="15.0875" id="M91" style="vertical-align:-2.3205pt" version="1.1" viewbox="0 0 24.35 15.0875" width="24.35" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,12.138)"><path d="M300 -147l-18 -23q-106 71 -159 185.5t-53 254.5v1q0 139 53 252.5t159 186.5l18 -24q-74 -62 -115.5 -173.5t-41.5 -242.5q0 -130 41.5 -242.5t115.5 -174.5z" id="x28"></path></g><g transform="matrix(.017,-0,0,-.017,5.944,12.138)"><path d="M716 28l-8 -28h-254l8 28q55 5 66 17.5t5 47.5l-30 145h-232l-74 -138q-21 -43 -11 -54.5t72 -17.5l-6 -28h-235l8 28q53 7 73.5 21t53.5 70l319 540l33 8q6 -43 33 -176l80 -381q10 -49 26.5 -63t72.5 -19zM495 281l-49 264h-2l-149 -264h200z" id="x1D434"></path></g><g transform="matrix(.017,-0,0,-.017,18.404,12.138)"><path d="M275 270q0 -296 -211 -440l-19 23q75 62 116.5 174t41.5 243t-42 243t-116 173l19 24q211 -144 211 -440z" id="x29"></path></g>
</svg> of the selected compounds on the microbial strains susceptible to the compounds in the qualitative screening assay.</table>

BioMed Research International

fig9

Figure 9

Figure 9: Synthesis and Antimicrobial Activity of Silver-Doped Hydroxyapatite Nanoparticles 